Target news
The WiseView Research desk's stories that name Target, the latest headlines about it, and the trades members of Congress and company insiders have disclosed. The TGT page →
- HeadlineFLG Cuts NII & EPS Outlook, Pushes 2027 Profitability Target to 2028
- HeadlineMeet the Dividend King That's Quietly Crushing the S&P 500 in 2026. Here's Why It's a Buy in November.
- HeadlineHome Depot vs. Target: Which Consumer Stock Is a Better Buy in 2026?
- HeadlineCostco vs. Target: Which Discount Retailer Should You Bet On?
- HeadlineGuidewire Investor Day: AI Push, Hyperexponential Deal Target $90B Insurance Opportunity
- HeadlineContango Provides Corporate Update: Kitsault Drill Program Exceeds Target, Johnson Tract Infrastructure Ahead of Plan, Lucky Shot 2070 East Drift Drilling Underway
- HeadlinePalvella Announces FDA Acceptance and Priority Review of QTORIN™ Rapamycin NDA; February 28, 2027 PDUFA Target Action Date Set
- HeadlineMithril Silver And Gold September 2026 Quarterly Report Target 4 Emerges As The Next Potential Resource Area And Target 1 Scoping Study/Pea Commenced
- HeadlineAdyen Shares Drop After Company Abandons Midterm Profitability Target
- HeadlineTarget #7 Geophysical Results Demonstrate Potential Scale of High-grade Skarn Mineralization at the Cotabambas Copper/Gold/Silver Project, Peru
- HeadlineOur Model and Wall Street Agree on Amazon's Target. Now the Quarter Has to Deliver.
- HeadlineTarget Reimagines Home Brand Threshold with More Style, Design and Value
- HeadlineTarget's Roundel Growth Highlights Rising Retail Media Value Ahead
- HeadlineVital Farms Introduces a Higher Standard for Free-Range Eggs Through Limited Pilot at Select Target Retail Stores
- HeadlineTwo Pills, One Target: Analyst Bets on Pharvaris as Clinical Risks Fade
- HeadlineDefense Play Elmet, Up 45% Since Its April IPO, Gets 50% Target Hike
- HeadlineOpenAI Just Cut Its Valuation Target by $150 Billion
- HeadlineDecade Samples Bonanza-Grade Gold up to 79.12 g/t and Silver up to 927 g/t in Boulders at Nobody Knows; VLF and Soil Anomaly Outlines Source Target
- HeadlineTarget Completes SoHo Store Transformation, Bringing Style and Design to Every Target Run
- HeadlineTarget Brings More Value and Delight to Thanksgiving with a $30 Meal for Six and Fresh Takes on Holiday Favorites
- HeadlineRivian Reaffirmed 65,000 to 70,000 Deliveries for 2026. Here's the Q4 Number Needed to Hit That Target.
- HeadlineAmazon vs. Target: Where Should Long-Term Investors Put Their Money?
- HeadlineTarget (TGT) Stock Sinks As Market Gains: Here's Why
- HeadlineTGT or TJX: Which Is the Better Value Stock Right Now?
- HeadlineDassault Systèmes: Lowering My Target, Looking At The Prospects
- HeadlineAIFU To Acquire Shenzhen Waltz New Material, Expanding Its Presence in the High-Tech Sector
- HeadlineCan Abercrombie's Target Partnership Fuel Hollister's Growth?
- HeadlineCryptocurrency Stocks Rise Despite Piper Sandler Price Target Cuts: MARA and Hut 8 Gain 4%, Riot Holds Flat
- HeadlineAmazon Pops on a Target Raise. 59 Analysts, Zero Sells
- HeadlineAdamera Receives Inverted IP Data for the Max Copper-Gold Target as Surveying of the Last Line is Underway, South Hedley Project, British Columbia
- HeadlineShould Value Investors Buy Target (TGT) Stock?
- HeadlineAbitronix and Iveda Target New York Tri-State Expansion with AbitronixAI, Powered by Iveda
- HeadlineRoyal Road Advances Gold Exploration Target at El Alemán, GAM Project, Colombia
- HeadlineNiobiumX Mining Outlines the Principal Exploration Target at Its Shipshaw Niobium Property, Quebec
- HeadlineBrixton Metals Reports 97.0% Gold Recovery in Initial Metallurgical Work from the Trapper Gold Target
- HeadlineIntrepid Metals Reports Positive Gold Results from Mattie Gold Target and Provides Corral Copper Drilling Update
- HeadlineNatural Gas and Oil Forecast: Houthis Target Saudi Oil, Can WTI Break $99.72?
- HeadlineStock Market Today, Oct. 19: CoreWeave Rebounds on Goldman Sachs Buy Upgrade and $139 Price Target
- HeadlineFirst and Only Ulcerative Colitis Treat-to-Target Trial Shows Treating to Disease Clearance vs. Symptomatic Remission with ENTYVIO® (vedolizumab) Prolongs Time to First Disease-Related Complication
- HeadlineShould You Buy, Hold or Sell Target Stock at its Current Valuation?
- HeadlineTarget (TGT) is a Top-Ranked Value Stock: Should You Buy?
- HeadlineEupraxia Pharmaceuticals Reaches its Enrollment Target for the RESOLVE Trial Investigating EP-104GI for the Treatment of Eosinophilic Esophagitis
- HeadlineGoldHaven IP Survey Defines Broad Geophysical Target Along Strike of High-Grade Copper at Three Guardsmen
- HeadlineStock Market Today, Oct. 14: Plug Power Falls on Analyst Target Cuts and Concerns Over Rising Interest Rates
- HeadlineRocket Lab Provides Update on Neutron Development and Adjusts Target Launch Timing
- HeadlineTarget's Agentic Commerce Push Opens New Digital Growth Avenues
- HeadlineDeep Origin Announces Multi-Target AI-Driven Drug Discovery Collaboration with BioAge Labs; Validated Hits Confirmed against First Target
- HeadlineScorpio Gold Drills 2.94 g/t Gold over 36.42 Metres from 169.62 Metres at the Goldwedge Target at Manhattan
- HeadlineTarget (TGT) Registers a Bigger Fall Than the Market: Important Facts to Note
- HeadlineTake-Two Interactive Slides 5% as Wells Fargo Trims Estimates Behind $300 Target; Roblox Holds Flat, GameStop Barely Budges
- CongressRo Khanna sold $1,001 - $15,000 of TGT
- CongressRo Khanna sold $1,001 - $15,000 of TGT
- CongressRo Khanna sold $1,001 - $15,000 of TGT
- CongressDan Newhouse bought $1,001 - $15,000 of TGT
- CongressRo Khanna sold $1,001 - $15,000 of TGT
- CongressRo Khanna sold $1,001 - $15,000 of TGT
- CongressRo Khanna sold $1,001 - $15,000 of TGT
- CongressRo Khanna bought $1,001 - $15,000 of TGT
Headlines link to their publishers. Members of Congress disclose ranges, not exact amounts, and may file weeks after the trade; insider filings are open-market purchases and sales from SEC Form 4. For information only, not investment advice.